戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pneumonia virus of mice, a property known as heterologous immunity.
2 e is epidemiological proof that these impair heterologous immunity.
3 rity of transplant recipients as a result of heterologous immunity.
4 hogenesis of infection by a process known as heterologous immunity.
5 itope cross-reactivity likely contributes to heterologous immunity.
6 rms of beneficial and detrimental effects of heterologous immunity.
7  the memory pool in patterns consistent with heterologous immunity.
8 /beta TCRs for broad antiviral responses and heterologous immunity.
9 uence disease outcome through the process of heterologous immunity.
10   Because B cells have been shown to promote heterologous immunity against respiratory virus pathogen
11 ceptor, was required in mediating protective heterologous immunity against VV.
12 between viruses can play roles in protective heterologous immunity and damaging immunopathology.
13 in clonal dominance, may be a consequence of heterologous immunity and lead to viral escape.
14 rtoires is brought about under conditions of heterologous immunity and might have important consequen
15 s are dispensable for Lactobacillus-mediated heterologous immunity and were not crucial for promoting
16                              This is termed "heterologous immunity" and has not been assessed previou
17                                              Heterologous immunity associated with cross-reactive T-c
18 y therefore demonstrates CD4 T-cell-mediated heterologous immunity between a bacterium and virus.
19 ing a profound private specificity effect in heterologous immunity between these two viruses.
20                                  Examples of heterologous immunity between unrelated viruses and allo
21 the development of allosensitization through heterologous immunity, but the relationship between BK v
22 ings have direct implications for allogeneic heterologous immunity by demonstrating that despite a lo
23 pe (GLCTLVAML), that, under some conditions, heterologous immunity can lead to a significant broadeni
24                                              Heterologous immunity can shape outcome of infections an
25 re associated with protective homologous and heterologous immunity during ehrlichial infection.
26                               Although prior heterologous immunity had variable effects on disease, D
27 peptide-MHC, the role of TCR affinity during heterologous immunity has not been explored.
28 ells between different viral peptides, i.e., heterologous immunity, has been well characterized.
29 blockade could surmount the barrier posed by heterologous immunity in a fully allogeneic murine trans
30 at cross-reactive T cells mediate protective heterologous immunity in mice.
31      This study extends our understanding of heterologous immunity in the context of persistent viral
32                                              Heterologous immunity induced two patterns of disease ou
33 olism, viral reactivation or infections, and heterologous immunity influence SCAR development and cli
34              We used an established model of heterologous immunity involving sequential infection of
35 -induced immunopathology under conditions of heterologous immunity is a function of the private speci
36                                Virus-induced heterologous immunity is considered a barrier to transpl
37       Our findings challenge the notion that heterologous immunity is necessarily detrimental in LT a
38                                              Heterologous immunity is recognized as a significant bar
39                    This phenomenon, known as heterologous immunity, is dependent on the sequence of i
40 vidence suggests that some antibody-mediated heterologous immunity may be afforded by alphavirus infe
41                                        Thus, heterologous immunity may help explain why treatment of
42         We hypothesized that T cell-mediated heterologous immunity may induce asthma symptoms among s
43                                    Mimicking heterologous immunity may provide a means of enhancing b
44 ties of T-cell responses under conditions of heterologous immunity occur and have been linked to the
45   For the first time, our results illustrate heterologous immunity of virus-infected animals toward a
46                                              Heterologous immunity refers to a process in which a res
47 onstrated that homeostatic proliferation and heterologous immunity represent two naturally occurring
48                                              Heterologous immunity thus occurs between many viruses,
49 iral infection can lead to rejection through heterologous immunity to donor antigen directly mediated
50 research on NTM epidemiology, immunology and heterologous immunity to Mtb.
51 ften express functional cross-reactivity, or heterologous immunity, to other viruses and to allogenei
52 tivity with other antigens and play roles in heterologous immunity upon encounter with another pathog
53     A potent role for memory CD8+ T cells in heterologous immunity was shown with a respiratory mucos
54                           Surprisingly, this heterologous immunity was superior to homologous immunit
55 -immune C57BL/6J mice through the process of heterologous immunity, we questioned whether TNF was req
56 function, which is particularly important in heterologous immunity, when microbe-specific T cells cro
57 mory T cells are generated by the process of heterologous immunity, whereby memory T cells arising in
58 also find some evidence that the preexisting heterologous immunity which reduced attack rates in adul
59 sed as a persistent infection model to study heterologous immunity with LCMV.